West Reports Second-Quarter 2026 Results

{
  "signal_id": "d790f52b-7f70-7db4-f5c8-d656a66fd1d6",
  "signal_type": "news",
  "signal_subtype": "has_revenue",
  "detected_at": "2026-07-23T10:00:00+00:00",
  "company": {
    "name": "West Pharmaceutical Services",
    "domain": "westpharma.com"
  },
  "data": {
    "url": "https://www.prnewswire.com/news-releases/west-reports-second-quarter-2026-results-302832704.html",
    "title": "West Reports Second-Quarter 2026 Results",
    "excerpt": "Raising Full-Year Net Sales and EPS guidance EXTON, Pa. , July 23, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a leading provider of innovative, high-quality injectable solutions and services, today announced its financial results for the second quarter of 2026. Second-Quarter Summary (comparisons to prior-year period) Outlook for Full-Year and Third-Quarter 2026 Eric M. Green, President, Chief Executive Officer and Chair of the Board, commented: \"I am pleased to report strong second-quarter results, with net sales and adjusted EPS exceeding our expectations. Net sales increased 12.7% organically, driven by our High Value Product Components business which benefited from continued strength in Biologics, a favorable mix shift from HVP upgrades including Annex 1, and ongoing growth in GLP-1 elastomers. The robust sales growth drove strong operating income margin expansion as compared to prior year. As a result of our team's strong execution in the second quarter and improved outlook, we are increasing our full-year 2026 guidance.\" Proprietary Products Segment Net sales of $722.6 million grew by 16.6% and increased 15.5% on an organic basis. West Vantage Segment Net sales of $149.7 million increased by 2.0% and rose 0.8% on an organic basis. West Vantage accounted for 17% of total company net sales in the quarter. Full-Year 2026 Financial Guidance...",
    "summary": "West Pharmaceutical Services' Proprietary Products Segment reported net sales of $722.6 million for the second quarter of 2026, a 16.6% increase year-over-year.",
    "location": "Exton, Pennsylvania, USA",
    "planning": false,
    "image_url": "https://mmx.prnewswire.com/media/MS513349/west-pharma-large-Logo.jpg?id=OA2780622&p=facebook",
    "confidence": 0.95,
    "published_at": "2026-07-23T10:00:00Z",
    "location_data": [
      {
        "city": "Exton",
        "state": "Pennsylvania",
        "region": "Northern America",
        "country": "United States",
        "continent": "Americas",
        "fuzzy_match": false
      }
    ],
    "article_sentence": "Proprietary Products Segment Net sales of $722.6 million grew by 16.6% and increased 15.5% on an organic basis.",
    "amount_normalized": 722600000
  }
}

curl https://signals.autobound.ai/v1/signals/d790f52b-7f70-7db4-f5c8-d656a66fd1d6 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"westpharma.com","limit":20}'